How Hone Identifies Heart Risk Years Before Symptoms Show
Our multi-system approach catches cardiovascular disease when it’s most reversible.

When you go for an annual physical, your doctor does blood work to check your cholesterol. If the numbers look normal, they tell you everything is fine. And you believe them. Why wouldn’t you?
However, a normal-looking cholesterol panel doesn’t mean you’re not at risk of heart disease. Nearly half of people with “normal” results have underlying heart risks, and nearly three-quarters of heart attack patients have levels of LDL (“bad”) cholesterol that fall within normal range.1
Standard lipid panels that check only LDL, HDL, triglycerides, and total cholesterol ignore factors like inflammation, hormone imbalance, and metabolic disease that increase the risk for heart disease years before cholesterol numbers shift.
Heart disease doesn’t start with high cholesterol. It starts with inflammation that damages artery walls, metabolic shifts that produce harmful cholesterol particles, liver stress that impairs fat clearance, and hormone decline that affects vessel flexibility and clotting. Each of these can contribute to cardiovascular risk on its own. But the real danger is when they interact. Hone’s Heart Health program is built around tracking these four systems together — because that’s where early risk becomes visible.
How Hone Spots Heart Risk Early
Hone physicians assess cardiovascular risk across four areas: inflammation, metabolic health, liver health, and hormonal health. Here’s what each one reveals, and why we track them together.

Inflammation
Think of cholesterol as fuel. Sitting in an artery, it can be present but not immediately dangerous. But when chronic inflammation irritates and damages artery walls, it acts as heat that ignites that otherwise inert fuel, causing it to build into unstable plaques that can rupture and trigger a heart attack.
Hone measures immune markers and lipid markers as part of our comprehensive testing, values that are otherwise ignored by standard panels to check for inflammation. Among them:
- Neutrophil-to-lymphocyte ratio (NLR): Shows whether your immune system is quietly stuck in an inflammatory state.2
- Red cell distribution width (RDW): Checks the consistency of red blood cell size as a marker of inflammation.3
- LDL-to-ApoB ratio: Reveals the type of cholesterol particles in your bloodstream — large, relatively harmless particles or the small, dense kind that burrow into artery walls (ApoB), trigger an immune response, and drive plaque buildup. This can reveal risk even when your LDL cholesterol number looks normal.4
Metabolic health
How well your body processes sugar and fats directly affects your heart health. When cells stop responding properly to insulin — a condition called insulin resistance — blood sugar rises as glucose struggles to enter cells efficiently. The body compensates by producing more insulin, which drives excess glucose into fat storage and raises triglycerides (fats in your blood that, when elevated, can build up in artery walls and increase heart disease risk). At the same time, HDL cholesterol (the “good” kind that clears harmful particles from your arteries) levels fall, and cholesterol gets pushed into smaller, denser particles that are more likely to slip into artery walls and trigger plaque buildup.5
One of the strongest markers we have to assess metabolic health is the triglyceride-to-HDL ratio. When triglycerides rise and HDL drops, the ratio climbs. This can signal cardiovascular risk years before standard tests like fasting glucose or A1C.
Liver health
The liver plays a bigger role in heart health than most people realize. The liver clears fats from your bloodstream and is central to cholesterol production, inflammation signaling, and insulin sensitivity.
When your liver is under even mild stress — from factors like excess alcohol consumption, visceral fat, poor diet, metabolic dysfunction, or stress — fats linger in the blood longer, cholesterol handling becomes less efficient, and inflammatory signals increase. 6 7
Hone measures two liver enzymes, AST and ALT, to gauge how much stress the liver is under and whether the source is more likely metabolic (like fatty liver disease) or lifestyle-related (like alcohol). We also check the albumin-to-globulin ratio, which can reveal whether liver stress and chronic inflammation are building simultaneously — a combination that accelerates arterial damage.
Hormone health and blood health
Hormones keep blood vessels flexible, support how the body processes fats and sugar, and control how easily blood flows. When levels of key hormones decline, those functions degrade, and cardiovascular risk increases.
For men, healthy testosterone levels are crucial to cardiovascular health. It helps muscles use blood sugar efficiently and keeps blood vessels healthy. Low testosterone levels can lead to increased belly fat, reduced insulin sensitivity, and inflammation, a combination shown to raise heart attack risk by 50%.8
For women, estradiol (the body’s main form of estrogen) keeps blood vessels flexible and helps clear excess cholesterol. As estradiol declines during perimenopause and menopause, blood vessels stiffen, blood pressure rises, cholesterol builds up more easily, and changes in clotting increase the risk of heart attack and stroke.9 10 After menopause, a woman’s cardiovascular risk rises sharply, catching up to men of the same age within 10 years.11
Hone also monitors hematocrit — the percentage of red blood cells in your blood — for both men and women. When it’s too high, blood thickens and clot risk rises; too low, and the heart has to work harder to deliver oxygen. 12 13
Hone’s multi-system approach to heart health is validated by recent moves from leading heart organizations. In a sweeping update to their guidelines, released in March 2026, the American College of Cardiology and the American Heart Association suggest that preventing heart disease — which kills 1 in 3 Americans every year — requires testing and tracking multiple systems.14 15 16 They recommend doctors test for inflammation, insulin resistance, liver stress, and hormone decline to get a more complete picture of heart health now and in the future.
Why Hone Doctors Read Patterns Across Systems
A slightly elevated triglyceride level, read in isolation, might not cause too much alarm. But if immune markers and liver enzymes are also elevated, it signals that metabolic and inflammatory stress across multiple systems is accelerating cardiovascular risk.
This matters because cardiovascular disease can develop years — sometimes decades — before standard tests catch it, because the body actively compensates in ways that keep routine markers looking normal. When insulin resistance develops, for example, the liver releases more triglycerides to supply energy to muscles that can no longer use glucose efficiently, so triglycerides rise while blood sugar still appears controlled.
Those compensatory adjustments can hold for years. But when multiple systems show strain at once, they begin to fail and risk accelerates. Hone physicians look for signs that compensation is underway and intervene before that happens.

What Treatment Looks Like In Practice
Hone reduces heart disease risk by treating what’s driving risk. If LDL cholesterol is borderline high but testosterone is low, we may address the hormone imbalance first since restoring testosterone can improve how the body processes cholesterol. If inflammation markers are the most urgent signal, that’s where treatment starts.
If multiple systems are under significant strain, the approach becomes more intensive and coordinated across all of them.
The goal is to treat the root driver first, then build from there using a combination of medication (such as statins), hormone therapy, targeted supplements, and lifestyle support calibrated to where your risk actually sits. As the highest-risk factors stabilize, care expands to address the next layer, until risk across all four systems is under control.
The Bottom Line
Heart disease is largely preventable. The challenge is that it develops across multiple systems simultaneously years before standard lipid panels catch it. Hone measures four systems that can accelerate risk — inflammation, metabolic health, liver function, and hormonal health — and tracks how they interact over time. This unique approach allows our doctors to identify and treat risk while it’s still modifiable.
Leticia Fernández-Friera, et. al., (2017) Normal LDL-Cholesterol Levels Are Associated With Subclinical Atherosclerosis in the Absence of Risk Factors
↑Lee, Soo Jin, et al. (2025) Neutrophil-to-Lymphocyte Ratio, Bone Marrow, and Visceral Fat Metabolism as Predictors of Future Cardiovascular Disease in an Asymptomatic Healthy Population
↑Katsaros, Marios, et al. (2020) Red cell distribution width as a marker of activity in inflammatory bowel disease: a narrative review
↑Xiao, Li (2023) The LDL-C/ApoB ratio predicts cardiovascular and all-cause mortality in the general population
↑Centers for Disease Control and Prevention (2024) LDL and HDL Cholesterol and Triglycerides
↑American Heart Association (2025) Analyzing 3 biomarker tests together may help identify high heart disease risk earlier
↑Cleveland Clinic (2022) Triglycerides and Heart Health
↑Kaur, Hargun and Werstuck, Geoff H. (2021) The Effect of Testosterone on Cardiovascular Disease and Cardiovascular Risk Factors in Men: A Review of Clinical and Preclinical Data
↑Aditya Raj, et. al. (2023) The Impact of Menopause on Cardiovascular Aging: A Comprehensive Review of Androgen Influences
↑Carmel M. McEniery (2023) Transitioning the Menopause: A Stiff Challenge
↑American College of Cardiology (2024) Heart Health Declines Rapidly After Menopause
↑Nithya Krishnamurthy, et. al. (2023) Erythrocytosis Is Rare With Exogenous Testosterone in Gender-Affirming Hormone Therapy
↑MedlinePlus (2024) Hemocrit Test
↑American Heart Association (2026) ACC/American Heart Association Issue Updated Guideline for Managing Lipids, Cholesterol
↑Latha P. Palaniappan, et. al. (2026) 2026 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
↑American Heart Association (2025) Heart disease remains leading cause of death as key health risk factors continue to rise
↑
Real Science, Real Results
Get expert insights on fueling your body, supporting metabolism, and living longer—delivered to your inbox every Monday.
"*" indicates required fields

Editorial Policy: Science-Backed, Expert-Reviewed
The Edge upholds the highest standards of health journalism. We source research from peer-reviewed medical journals, top government agencies, leading academic institutions, and respected advocacy groups. We also go beyond the research, interviewing top experts in their fields to bring you the most informed insights. Every article is rigorously reviewed by medical experts to ensure accuracy. Contact us at support@honehealth.com if you see an error.
